Global In-Vitro Fertilization Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Product;
Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, and Reagents & Accessories.By Type;
Conventional IVF, and IVF with ICSI.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).Introduction
Global In-Vitro Fertilization Market (USD Million), 2021 - 2031
In the year 2023, the Global In-Vitro Fertilization Market was valued at USD 6,571.75 million. The size of this market is expected to increase to USD 11,783.87 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 8.7%.
IVF, a sophisticated medical procedure, involves the fertilization of an egg with sperm outside the body, typically in a laboratory setting, followed by the transfer of the resulting embryo(s) into the uterus. This technique offers hope to individuals and couples facing infertility due to various factors, including hormonal imbalances, tubal blockages, male factor infertility, and advanced maternal age, among others.
The market for in-vitro fertilization is characterized by significant technological advancements, evolving regulatory landscapes, and shifting societal attitudes towards fertility treatments. Technological innovations in IVF techniques, such as intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and time-lapse embryo monitoring, have revolutionized the field, improving pregnancy rates, reducing the risk of multiple pregnancies, and enhancing the overall safety and efficacy of IVF procedures.
Changing regulatory frameworks governing ART practices and reimbursement policies for fertility treatments have influenced market dynamics, shaping access to IVF services and influencing healthcare provider practices and patient preferences. Additionally, societal trends, including delayed childbearing, increasing awareness of fertility preservation options, and growing acceptance of alternative family-building arrangements, have contributed to the expansion of the global IVF market, driving demand for IVF services and related technologies.
Geographically, the Global IVF Market exhibits variations in market size, regulatory environments, and healthcare infrastructure across regions. Developed economies in North America and Europe lead the market in terms of technological innovation, healthcare expenditure, and accessibility of IVF services, while emerging markets in Asia Pacific, Latin America, and the Middle East and Africa are witnessing rapid growth, driven by increasing healthcare investments, rising disposable incomes, and changing cultural norms regarding fertility treatments.
Global In-Vitro Fertilization Market Recent Developments
- In January 2022, Ferring Pharmaceuticals announced the acquisition of Merck's global in vitro fertilization (IVF) business.
- In February 2022, AbbVie and SpringWorks Therapeutics announced a collaboration to develop IVF treatments for infertility.
- In March 2022, Merck KGaA acquired ART Reproductive Center, a leading provider of IVF services in the US.
- In April 2022, KKR announced the acquisition of ReproSource, a provider of IVF services and products.
- In May 2022, Bayer AG acquired the IVF business of Merck Serono, a subsidiary of Merck KGaA.
- In June 2022, Myriad Genetics announced the acquisition of Reprogenetics, a provider of IVF genetic testing services.
Segment Analysis
The segmentation by Product encompasses a wide range of technologies, equipment, and consumables used in the IVF process, including IVF media, cryopreservation devices, sperm separation systems, and incubators, among others. Each product category plays a crucial role in supporting various stages of the IVF procedure, from gamete manipulation and fertilization to embryo culture and transfer, contributing to the overall success and efficiency of IVF treatments.
The segmentation by Type encompasses different variations and techniques within the IVF procedure, including conventional IVF, intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and donor egg IVF, among others. Each type of IVF procedure offers unique advantages and applications, catering to specific patient populations and clinical scenarios, such as male factor infertility, advanced maternal age, or genetic disorders, thereby expanding the scope of IVF treatments and addressing diverse patient needs.
Geographically, the market segmentation provides insights into regional trends, market dynamics, and growth opportunities across different geographical regions. This includes established markets in North America and Europe, where advanced healthcare infrastructure, favorable reimbursement policies, and high patient awareness drive market growth, as well as emerging markets in Asia Pacific, Latin America, and the Middle East and Africa, where increasing healthcare expenditure, rising prevalence of infertility, and improving accessibility of IVF services contribute to market expansion.
Global In-Vitro Fertilization Segment Analysis
In this report, the Global In-Vitro Fertilization Market has been segmented by Product, Type, and Geography.
Global In-Vitro Fertilization Market, Segmentation by Product
The Global In-Vitro Fertilization Market has been segmented by Product into Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, and Reagents & Accessories.
Micromanipulators play a pivotal role in the manipulation of gametes during the IVF process, facilitating procedures such as intracytoplasmic sperm injection (ICSI) and embryo biopsy with precision and accuracy. These sophisticated instruments enable embryologists to handle individual sperm cells and embryos with utmost care, ensuring optimal conditions for fertilization and embryo development.
Incubators are essential components of the IVF laboratory, providing a controlled environment conducive to embryo culture and development. These specialized devices regulate temperature, humidity, and gas concentration levels to mimic the conditions of the female reproductive tract, optimizing embryo viability and growth. Cabinets are utilized for the storage and preservation of gametes and embryos, maintaining their viability during cryopreservation and ensuring safe and secure storage until future use.
Imaging systems, including microscopes and cameras, enable embryologists to monitor and assess the progression of fertilization and embryo development in real-time. High-resolution imaging technology allows for detailed examination of gametes and embryos, facilitating the selection of high-quality embryos for transfer and increasing the likelihood of successful implantation. Laser systems are utilized in assisted hatching procedures, where precise laser pulses are used to create an opening in the zona pellucida of the embryo, enhancing its ability to implant into the uterine lining. Reagents and accessories encompass a wide range of consumables and supplies used in the IVF laboratory, including culture media, cryoprotectants, pipettes, and culture dishes. These essential components support various stages of the IVF process, from oocyte retrieval and sperm preparation to embryo culture and transfer, ensuring optimal conditions for successful fertilization and embryo development.
Global In-Vitro Fertilization Market, Segmentation by Type
The Global In-Vitro Fertilization Market has been segmented by Type into Conventional IVF, and IVF with ICSI.
Conventional IVF, the traditional method of fertilization, involves the mixing of retrieved eggs and sperm in a laboratory dish, allowing fertilization to occur naturally. This technique is suitable for couples with mild to moderate male factor infertility, as well as cases where the quality of sperm is adequate for fertilization without additional assistance.
IVF with Intracytoplasmic Sperm Injection (ICSI) is a specialized technique designed to overcome severe male factor infertility by directly injecting a single sperm into the cytoplasm of the egg using a fine needle. This precise microinjection method bypasses natural barriers to fertilization, ensuring successful fertilization even in cases of low sperm count, poor sperm motility, or abnormal sperm morphology. ICSI is also recommended for couples undergoing IVF with previous failed fertilization attempts, where conventional IVF has proven ineffective in achieving fertilization. The choice between Conventional IVF and IVF with ICSI depends on various factors, including the underlying cause of infertility, the quality of the sperm and eggs, and the couple's reproductive history. While Conventional IVF remains a viable option for many couples, ICSI offers a targeted solution for cases of severe male factor infertility or previous IVF failures, providing hope for couples struggling to conceive naturally.
Global In-Vitro Fertilization Market, Segmentation by Geography
In this report, the Global In-Vitro Fertilization Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Global In-Vitro Fertilization Market Share (%), by Geographical Region, 2024
North America, comprising the United States and Canada, stands as a mature market for IVF, driven by advanced healthcare systems, high disposable incomes, and favorable reimbursement policies. The region boasts a robust network of fertility clinics, research institutions, and industry players, fostering innovation and adoption of cutting-edge IVF technologies and techniques.
Europe, encompassing countries such as the United Kingdom, Germany, France, and Spain, similarly exhibits a well-established IVF market, supported by universal healthcare coverage and strong regulatory oversight. European countries lead in terms of IVF treatment cycles and success rates, with a growing emphasis on patient-centric care and personalized medicine.
The Asia Pacific region, including China, Japan, India, and Australia, represents a rapidly expanding market for IVF, fueled by rising infertility rates, increasing healthcare expenditure, and improving access to fertility treatments. Urbanization, changing lifestyles, and delayed childbearing contribute to the growing demand for IVF services in the region, prompting investments in IVF clinics and adoption of innovative treatment modalities.
In the Middle East and Africa, IVF markets vary widely across countries, influenced by cultural, religious, and socioeconomic factors. While some Gulf countries offer advanced IVF services with state-of-the-art facilities, others face challenges related to healthcare infrastructure, affordability, and cultural stigmas surrounding infertility treatments.
Latin America, comprising countries such as Brazil, Mexico, and Argentina, presents a diverse IVF landscape characterized by varying levels of healthcare development and accessibility. The region witnesses growing demand for fertility treatments driven by changing family structures, increasing female workforce participation, and expanding insurance coverage for reproductive services.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global In-Vitro Fertilization Market. These factors include; Market Drivers, Restraints and Opportunities.
Drivers:
- Technological Advancements
- Changing Regulatory Landscape
-
Societal Acceptance - One of the primary drivers behind this societal acceptance is the growing recognition of infertility as a widespread issue affecting millions of individuals and couples globally. As infertility rates rise due to factors such as delayed childbearing, environmental pollutants, lifestyle choices, and medical conditions, there has been a corresponding increase in public awareness and empathy towards those struggling to conceive. This shift in perspective has led to greater advocacy for fertility treatments and support services, reducing the stigma associated with seeking medical assistance for infertility.
Advancements in medical technology and ART procedures have played a pivotal role in enhancing the success rates and safety profile of IVF treatments, further contributing to societal acceptance. As IVF becomes increasingly accessible, affordable, and effective, more individuals and couples are willing to explore fertility treatments as a viable option for starting or expanding their families.
Changing cultural norms and evolving family structures have also influenced societal acceptance of IVF and other fertility treatments. With changing perceptions of parenthood, family-building, and gender roles, there is greater openness to alternative reproductive options, including donor sperm, donor eggs, surrogacy, and adoption, among others. This cultural shift towards inclusivity and diversity in family formation has created a more supportive environment for individuals and couples pursuing IVF treatments.
Restraints:
- High Cost Barrier
- Ethical Concerns
-
Limited Access - Limited access to IVF treatment stems from various factors, including financial barriers, geographic disparities, and healthcare infrastructure constraints. The high cost associated with IVF procedures, including consultation fees, diagnostic tests, medication, and treatment cycles, often renders IVF services financially inaccessible for individuals without adequate insurance coverage or financial means. This financial burden can be exacerbated by the absence of insurance coverage for fertility treatments in many healthcare systems, leaving patients to bear the full cost of treatment out of pocket.
Geographic disparities in access to IVF services also contribute to limited accessibility, particularly in rural or remote areas where specialized fertility clinics may be scarce or nonexistent. In such regions, individuals and couples seeking IVF treatment may face challenges in accessing comprehensive fertility care, including diagnostic assessments, treatment consultations, and ongoing support services. Moreover, disparities in healthcare infrastructure and resources between urban and rural areas can further exacerbate disparities in access to IVF treatment, perpetuating inequities in healthcare delivery.
Sociocultural factors and legal restrictions in certain countries may pose barriers to access to IVF treatment, particularly for marginalized populations or individuals belonging to minority groups. Cultural stigmas surrounding infertility and ART, as well as legal restrictions on reproductive rights and fertility treatments, can deter individuals from seeking IVF services or accessing them discreetly and without discrimination.
Opportunities:
- Emerging Markets Expansion
- Fertility Tourism Growth
-
Genetic Screening Adoption - Genetic screening, also known as preimplantation genetic testing (PGT), involves the analysis of embryos created through IVF to identify genetic abnormalities or chromosomal anomalies before implantation. This screening process enables healthcare providers to select embryos with the highest likelihood of implantation and healthy development, thereby reducing the risk of genetic disorders and improving the chances of a successful pregnancy.
The adoption of genetic screening in the IVF market offers several benefits for patients and healthcare providers alike. Firstly, it provides couples undergoing IVF with valuable information about the genetic health of their embryos, allowing them to make informed decisions regarding embryo selection and family planning. By identifying embryos free from genetic abnormalities, genetic screening minimizes the risk of miscarriage and pregnancy complications, offering reassurance to prospective parents and improving overall pregnancy outcomes.
Genetic screening contributes to the prevention of inherited genetic diseases by enabling the detection and elimination of embryos carrying disease-causing mutations. This proactive approach to genetic screening helps to break the cycle of hereditary conditions within families and reduces the burden of genetic disorders on future generations. Additionally, genetic screening can enhance the efficiency of IVF procedures by optimizing embryo selection and reducing the need for repeated IVF cycles, thereby lowering overall treatment costs and improving patient satisfaction.
Competitive Landscape Analysis
Key players in Global In-Vitro Fertilization Market include:
- Cooper Companies Inc. (US)
- Cook Group (US)
- Vitrolife (Sweden)
- Thermo Fisher Scientific, Inc. (US)
- Esco Micro Pte. Ltd. (Singapore)
- Genea Limited (Australia)
- IVFtech ApS (Denmark)
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Type
- Market Snapshot, By Region
- Global In-Vitro Fertilization Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
-
Technological Advancements
-
Changing Regulatory Landscape
-
Societal Acceptance
-
- Restraints
-
High Cost Barrier
-
Ethical Concerns
-
Limited Access
-
- Opportunities
-
Emerging Markets Expansion
-
Fertility Tourism Growth
-
Genetic Screening Adoption
-
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global In-Vitro Fertilization Market, By Product, 2021 - 2031 (USD Million)
-
Micromanipulators
-
Incubators
-
Cabinets
-
Imaging System
-
Laser System
-
Reagents & Accessories
-
- Global In-Vitro Fertilization Market, By Type, 2021 - 2031 (USD Million)
-
Conventional IVF
-
IVF with ICSI
-
- Global In-Vitro Fertilization Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global In-Vitro Fertilization Market, By Product, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Cooper Companies Inc. (US)
- Cook Group (US)
- Vitrolife (Sweden)
- Thermo Fisher Scientific, Inc. (US)
- Esco Micro Pte. Ltd. (Singapore)
- Genea Limited (Australia)
- IVFtech ApS (Denmark)
- Company Profiles
- Analyst Views
- Future Outlook of the Market